市场调查报告书
商品编码
1470871
呼吸照护设备市场:按产品、适应症和最终用户划分 - 全球预测 2024-2030Respiratory Care Devices Market by Product (Consumables & Accessories, Diagnostic Devices, Monitoring Devices), Indication (Asthma, Chronic Obstructive Pulmonary Disease, Infectious Disease), End-User - Global Forecast 2024-2030 |
※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。
预计2023年呼吸护理设备市场规模为198.7亿美元,预计2024年将达210.8亿美元,2030年预计将达306.6亿美元,复合年增长率为6.39%。
呼吸照护设备市场包括用于诊断、监测、治疗和管理呼吸系统疾病的各种医疗设备、装置和消耗品。这些医疗设备用于为有长期照护需求的患者提供医疗保健环境,包括医院、诊所、门诊手术中心和居家照护。推动呼吸照护设备市场的主要因素是由于空气污染水平上升和烟草使用增加导致呼吸系统疾病盛行率上升,导致慢性阻塞性肺病和气喘病例。该市场成长面临的限制和挑战包括与先进医疗设备相关的高成本,这限制了可及性,以及由于复杂设备的不当处理或滥用而导致併发症和感染疾病的风险。市场开拓公司专注于开发紧凑且易于使用的便携式设备。此外,透过将先进技术整合到呼吸护理解决方案中,对具有更高耐用性和数位连接性的轻质部件进行材料科学研究,以改善患者照护的协调性,这将为全球呼吸护理设备市场带来机会。
主要市场统计 | |
---|---|
基准年[2023] | 198.7亿美元 |
预测年份 [2024] | 210.8亿美元 |
预测年份 [2030] | 306.6亿美元 |
复合年增长率(%) | 6.39% |
产品对呼吸照护设备的基本消耗品和配件的需求不断增加
耗材和配件是呼吸照护设备有效运作的重要组成部分。这包括呼吸管路、一次性口罩、氧气鼻管、气切管等。所有类别的消耗品和配件都有很高的需求,因为它们必须经常更换,以保持卫生并防止需要呼吸支持的患者感染的风险。诊断设备透过测量肺活量、气道阻力和气体交换效率来识别气喘、慢性阻塞性肺病(COPD) 和睡眠呼吸中止症等呼吸系统疾病至关重要。常见的诊断工具包括肺计量计、睡眠多项生理检查(PSG) 和峰值流量计 (PFM)。此监测设备使用各种感测器来追踪患者的呼吸模式,并将资料发送给医疗保健专业人员,以即时分析氧气水平和气流阻塞事件。此类设备包括脉动式血氧监测仪系统和气体分析仪。治疗设备为呼吸衰竭患者提供持续或间歇性支持,并提供氧气疗法治疗、非侵入性通气 (NIV)、机械通气、雾化器和加湿器等治疗选择。
适应族群中呼吸道疾病的盛行率增加
气喘是一种慢性肺部疾病,其特征是气道发炎,导致喘息、咳嗽、气短和胸闷。为气喘开发的呼吸护理设备包括吸入器、雾化器和峰值流量计。慢性阻塞性肺病(COPD)是一组进行性肺部疾病,患者气流因暴露于空气污染和香烟烟雾等刺激物而受阻。常见症状包括咳嗽、气短、喘息并伴随黏液和胸闷。用于 COPD 管理的呼吸护理设备包括氧气浓缩机、人工呼吸器、正压呼吸器(PAP)设备和脉动式血氧监测仪系统。结核病和肺炎等呼吸道感染疾病需要特定的呼吸照护设备,例如高流量氧气鼻管(HFNC)治疗系统和机械人工呼吸器,以在严重感染疾病期间支持呼吸。睡眠呼吸中止症是一种睡眠障碍,其特征是呼吸模式中断,导致睡眠品质不佳和白天疲劳。 CPAP(持续性正压呼吸器)机器是治疗睡眠呼吸中止症的常见治疗方法,可维持持续气流以防止睡眠期间气道塌陷。
最终用户:对具有远端监控功能的易于使用的设备的需求不断增长,以提高居家照护环境中患者的用药依从性。
由于需要定期监测和治疗的呼吸系统疾病患者数量不断增加,门诊医疗中心对呼吸照护设备的需求不断增加。门诊医疗中心使用的设备包括雾化器、氧气浓缩机、脉动式血氧监测仪系统和人工呼吸器。居家医疗涉及患者在自己的家中单独或在经过培训的看护者的帮助下使用呼吸护理设备。家庭医疗保健的成长趋势增加了对易于使用的可携式呼吸器的需求,这些呼吸器可以由患者和看护者轻鬆操作。由于大量患者需要加护治疗、术后护理和紧急呼吸支持,医院和诊所是呼吸护理设备的重要最终用户区域。
区域洞察
由于一般民众对各种呼吸系统疾病的认识不断提高以及该地区主要企业的存在,美洲呼吸照护设备市场正在经历成长。推动这一成长的因素包括医疗基础设施的改善、有利的报销政策以及市场参与企业更多地采用先进技术。在欧洲、中东和非洲地区,由于人口老化,更容易患慢性阻塞性肺病(COPD)等慢性呼吸道疾病,呼吸照护设备市场正在显着扩大。此外,旨在降低医疗保健成本的政府措施正在推动该地区家庭呼吸护理设备的采用。此外,中东地区政府对医疗基础设施的支出增加正在推动欧洲、中东和非洲地区对呼吸照护设备的需求。亚太地区是全球呼吸照护设备市场成长最快的地区之一。由于人口快速增长,中国、印度和日本的慢性呼吸道疾病正在迅速增加。此外,亚太地区主要城市的空气污染程度较高,导致居民呼吸道疾病的盛行率增加。再加上医疗基础设施的改善、人们对呼吸道疾病的认识不断提高以及可支配收入的增加,正在推动该地区的市场成长。
FPNV定位矩阵
FPNV定位矩阵对于评估呼吸照护设备市场至关重要。我们检视与业务策略和产品满意度相关的关键指标,以对供应商进行全面评估。这种深入的分析使用户能够根据自己的要求做出明智的决策。根据评估,供应商被分为四个成功程度不同的像限:前沿(F)、探路者(P)、利基(N)和重要(V)。
市场占有率分析
市场占有率分析是一种综合工具,可以对呼吸照护设备市场供应商的现状进行深入而深入的研究。全面比较和分析供应商在整体收益、基本客群和其他关键指标方面的贡献,以便更好地了解公司的绩效及其在争夺市场占有率时面临的挑战。此外,该分析还提供了对该行业竞争特征的宝贵见解,包括在研究基准年观察到的累积、分散主导地位和合併特征等因素。这种详细程度的提高使供应商能够做出更明智的决策并制定有效的策略,从而在市场上获得竞争优势。
1. 市场渗透率:提供有关主要企业所服务的市场的全面资讯。
2. 市场开拓:我们深入研究利润丰厚的新兴市场,并分析其在成熟细分市场的渗透率。
3. 市场多元化:提供有关新产品发布、开拓地区、最新发展和投资的详细资讯。
4.竞争力评估与资讯:对主要企业的市场占有率、策略、产品、认证、监管状况、专利状况、製造能力等进行全面评估。
5. 产品开发与创新:提供对未来技术、研发活动和突破性产品开发的见解。
1.呼吸护理设备市场的市场规模与预测是多少?
2.呼吸照护设备市场预测期间需要考虑投资的产品、细分市场、应用和领域有哪些?
3.呼吸护理设备市场的技术趋势和法规结构是什么?
4.呼吸护理设备市场主要厂商的市场占有率为何?
5.进入呼吸照护设备市场合适的型态和策略手段是什么?
[189 Pages Report] The Respiratory Care Devices Market size was estimated at USD 19.87 billion in 2023 and expected to reach USD 21.08 billion in 2024, at a CAGR 6.39% to reach USD 30.66 billion by 2030.
The respiratory care devices market encompasses various medical devices, equipment, and consumables utilized for the diagnosis, monitoring, treatment, and management of respiratory diseases. These devices are employed in healthcare settings, including hospitals, clinics, ambulatory surgical centers, and homecare situations by patients who require long-term care. Key factors driving the respiratory care devices market are the rising prevalence of respiratory diseases owing to increasing air pollution levels and tobacco usage, leading to COPD and asthma cases. Limitations & challenges faced by the growth of this market include high costs associated with advanced medical equipment limiting accessibility and risk of complications or infections due to improper handling or misuse of complex devices. Market companies are focusing on developing compact, user-friendly portable devices. Moreover, research into material science for lighter-weight components with improved durability and digital connectivity enabling improved patient care coordination by integrating advanced technologies into respiratory care solutions is creating lucrative opportunities for the global respiratory care devices market.
KEY MARKET STATISTICS | |
---|---|
Base Year [2023] | USD 19.87 billion |
Estimated Year [2024] | USD 21.08 billion |
Forecast Year [2030] | USD 30.66 billion |
CAGR (%) | 6.39% |
Product: Growing need for essential consumables and accessories for respiratory care devices
Consumables and accessories are essential components for the effective functioning of respiratory care devices. These include breathing circuits, disposable masks, nasal cannulas, and tracheostomy tubes. Consumables and accessories are highly demanded across all categories owing to their frequent replacement need to maintain hygiene and prevent infection risks in patients who require respiratory support. Diagnostic devices are crucial in identifying respiratory disorders such as asthma, chronic obstructive pulmonary disease (COPD), sleep apnea, and other breathing issues by measuring lung volume, airway resistance, and gas exchange efficiency. Common diagnostic tools include spirometers, polysomnographs (PSG), and peak flow meters (PFM). Monitoring devices track a patient's breathing patterns using various sensors that transmit data to healthcare professionals for real-time analysis of oxygen levels or airflow obstruction events. These devices include pulse oximeters and gas analyzers. Therapeutic devices facilitate continuous or intermittent support for patients with respiratory insufficiency, offering treatment options such as oxygen therapy, non-invasive ventilation (NIV), mechanical ventilation, nebulizers, and humidifiers.
Indication: Rising prevalence of respiratory disorders among population
Asthma is a type of chronic lung disease characterized by airway inflammation, leading to wheezing, coughing, shortness of breath, and chest tightness. Respiratory care devices designed for asthma include inhalers, nebulizers, and peak flow meters. Chronic obstructive pulmonary disease (COPD) is a group of progressive lung diseases that obstruct airflow owing to exposure to irritants such as air pollution or tobacco smoke. Common symptoms include coughing, shortness of breath, wheezing with mucus, and chest tightness. Respiratory care devices for COPD management include oxygen concentrators, ventilators, positive airway pressure (PAP) devices, and pulse oximeters. Respiratory infectious diseases such as tuberculosis or pneumonia require specific respiratory care devices, including high-flow nasal cannula (HFNC) therapy systems or mechanical ventilators to support breathing during severe infections. Sleep apnea is a sleep disorder characterized by interrupted breathing patterns leading to poor-quality sleep and daytime fatigue. Continuous Positive Airway Pressure (CPAP) devices is the common treatment for sleep apnea that maintain continuous airflow to prevent airway collapse during sleep.
End-User: Emerging demand for user-friendly devices with remote monitoring capabilities to facilitate better patient adherence in home care settings
Ambulatory care centers have an increasing demand for respiratory care devices owing to the growing number of patients with respiratory conditions who require regular monitoring and treatment. The equipment used in ambulatory care centers includes nebulizers, oxygen concentrators, pulse oximeters, and ventilators. Home care settings involve the use of respiratory care devices by patients at home, either independently or with assistance from trained caregivers. The increasing trend towards home healthcare has led to a rise in demand for user-friendly and portable respiratory devices that can be easily operated by both patients and their caregivers. Hospitals and clinics represent a significant end-user segment for respiratory care devices owing to the high volume of patients requiring intensive care, post-operative care, or emergency respiratory support.
Regional Insights
The Americas has experienced growth in its respiratory care devices market owing to increasing awareness regarding various respiratory disorders among the general population and the strong presence of key market companies in this region. Factors driving this growth include improving healthcare infrastructure, favorable reimbursement policies, and the growing adoption of advanced technologies by market players. The EMEA region has seen significant expansion within its respiratory care devices market owing to an aging population prone to chronic respiratory diseases, including COPD. Furthermore, government initiatives aimed at reducing healthcare costs are encouraging the adoption of home respiratory care devices within this region. Furthermore, increased government spending on healthcare infrastructure in the Middle East region has augmented the demand for respiratory care devices within EMEA. APAC is expected to be one of the fastest-growing regions in the global respiratory care devices market. The rapidly increasing population in China, India, and Japan has led to a surge in chronic respiratory diseases. Additionally, high air pollution levels in major cities across Asia-Pacific are contributing to an increased prevalence of respiratory ailments among its residents. This, coupled with improving healthcare infrastructure, growing awareness about respiratory disorders among the populace, and rising disposable incomes, have fostered market growth within this region.
FPNV Positioning Matrix
The FPNV Positioning Matrix is pivotal in evaluating the Respiratory Care Devices Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).
Market Share Analysis
The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Respiratory Care Devices Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.
Key Company Profiles
The report delves into recent significant developments in the Respiratory Care Devices Market, highlighting leading vendors and their innovative profiles. These include Advin Health Care, Allied Medical LLC, Baxter International, Inc., Catalent, Inc., Dragerwerk AG & Co. KGaA, Fisher & Paykel Healthcare Limited, Flexicare (Group) Limited, GE HealthCare Technologies Inc., Getinge AB, Hamilton Medical AG, Invacare Corporation, Koninklijke Philips N.V., Leistung, L'Air Liquide S.A., Masimo Corp., Max Ventilator by A.B.Industries, Medline Industries, LP, Medtechlife, Medtronic PLC, Nihon Kohden Corporation, Nonin Medical, Inc., Omron Corporation, React Health, ResMed Corp., Schiller AG, Smiths Group PLC, Teleflex Incorporated, Thermo Fisher Scientific Inc., Vyaire Medical, Inc., and ZOLL Medical Corporation by Asahi Kasei Corporation.
Market Segmentation & Coverage
1. Market Penetration: It presents comprehensive information on the market provided by key players.
2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.
1. What is the market size and forecast of the Respiratory Care Devices Market?
2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Respiratory Care Devices Market?
3. What are the technology trends and regulatory frameworks in the Respiratory Care Devices Market?
4. What is the market share of the leading vendors in the Respiratory Care Devices Market?
5. Which modes and strategic moves are suitable for entering the Respiratory Care Devices Market?